Current LA BioMed President Kenneth Trevett brings 26 years
of related leadership experience to his new position
(San Antonio) – Southwest Foundation for Biomedical Research
Chairman J.R. Hurd announced today that SFBR’s Board of Trustees
has named Kenneth P. Trevett as the organization’s new
President. In late September, he will succeed John C. Kerr, a
trustee and former SFBR Chairman, who has served as Interim
President since June of 2006.
Trevett, an attorney, comes to the position with 26 years of
senior management experience at independent research institutes
such as SFBR, including his current position as President and
CEO of Los Angeles Biomedical Research Institute at Harbor-UCLA
Medical Center ("LA BioMed"), one of the largest independent
biomedical research organizations in California. Previously he
served as a senior administrator and legal counsel for The
Schepens Eye Research Institute in Boston, an affiliate of
Harvard Medical School; the Dana-Farber Cancer Institute in
Boston; and The Jackson Laboratory in Bar Harbor, Maine.
In addition to his responsibilities at LA BioMed, Trevett has
served on numerous city and state research and economic
development boards, and in the 1990s, he was elected to a
two-year term as President of the Association of Independent
Research Institutes, the national coalition of SFBR’s peer
organizations.
"We are very pleased to have someone of Ken Trevett’s caliber
take the helm at SFBR," Hurd said. "His appointment is the
culmination of an extensive national search that included
numerous highly qualified candidates from across the country,
resulting in the selection of a truly outstanding new chief
executive for SFBR."
Hurd continued, "With Ken Trevett’s high-level management
experience at several of the leading independent biomedical
research organizations in this country – especially when coupled
with his legal background and his experience in philanthropic
fundraising and the commercialization of research discoveries –
he is exceptionally well qualified to lead the Foundation to
even higher levels of achievement."
Kerr, who will continue as a member of SFBR’s Board of
Trustees, said, "I am delighted to welcome Ken Trevett as the
Foundation’s new President. With his proven leadership ability
at several of the nation’s preeminent research institutions, he
is an ideal fit for SFBR. I look forward to a close working
relationship with him in my continuing role as a trustee."
Among his many accomplishments at LA BioMed, Trevett is
credited with creating a more collaborative environment,
developing a sophisticated technology transfer program for the
commercialization of promising technology in the patient care
arena, leading the organization through a campus modernization
effort, attracting additional revenues to the institution, and
increasing awareness of the organization within the greater Los
Angeles area.
He has authored a CD-ROM and lectured and consulted
extensively relating his knowledge on the licensing of academic
technology, including teaching a course on the subject at his
alma mater, the Suffolk University School of Law in Boston. Now
he said he is looking forward to using his skills for the
further enhancement of SFBR.
"The opportunity to serve as president of one of the finest
biomedical research organizations in the country is an honor
that is tremendously exciting for me," Trevett said. "Southwest
Foundation is in an extraordinary position, with excellent
scientific leadership, outstanding faculty with a strong track
record of research success, an incredible Board of Trustees,
significant resources, and a staff that is fully committed to
the international mission of the organization. I believe it will
be enjoyable and challenging to build on the organization’s
great tradition of research productivity as we strive for even
greater impact worldwide."
Trevett believes his job as a non-scientist leader of SFBR
will be to create the best environment possible for the
scientists to carry out their work. "The Foundation already has
a great track record of success, so now it’s a matter of further
enhancing the environment for research excellence."
Hurd pointed out that Trevett is joining SFBR at a time when
the organization is at its strongest position, both
scientifically and financially, in its 67-year history, and he
thanked John Kerr for his dedication and service in guiding it
toward success. "We owe John a debt of gratitude. He’s led the
organization to a point where it is very well positioned, and
now Ken Trevett can help us take it to the next phase."
Southwest Foundation for Biomedical Research is one of the
leading independent biomedical research institutions in the
United States, dedicated to advancing human health through
innovative biomedical research. It is recognized within
scientific and academic communities worldwide for the quality of
its basic research into the nature, causes, preventions, and
treatments for disease. SFBR’s staff of more than 85
doctoral-level scientists conducts nearly 200 major research
projects, with marked success in the areas of genetics, neonatal
development, metabolic disorders and infectious diseases.